Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Voluven vs Albumin in Postoperative Complications
NCT00308126Phase 4Completed
- Sponsor
- Fresenius Kabi
- Start
- Jun 2005
- Modality
- Polymer-based Nanoparticles, Lipid-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of Volulyte in postoperative complications, sponsored by Fresenius Kabi. Started Jun 2005; status: completed.
02
Drugs
Volulyte
03
Conditions
postoperative complications
Beyond the preview
Go deeper on NCT00308126.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00308126.